FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


15270 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
DNA från progressivt pneumonivirus hos får Deoxyribonucleic acid of microorganism (substance)
DNA från Pseudorabiesvirus Deoxyribonucleic acid of microorganism (substance)
DNA från Taylorella equigenitalis Deoxyribonucleic acid of microorganism (substance)
DNA från Theileria mutans Deoxyribonucleic acid of microorganism (substance)
DNA från Theileria parva Deoxyribonucleic acid of microorganism (substance)
DNA från Trypanosoma evansi Deoxyribonucleic acid of microorganism (substance)
Department of Health and Social Security (DHSS) medical examination NOS Specialized medical examination
beroende av dissociativa substanser Hallucinogen dependence
beroende av okänd substans Substance dependence (disorder)
territorium avhängigt av Förenade kungariket Storbritannen och Nordirland British Overseas Territories (geographic location)
administrering av Provera depot-injektion Injection of medroxyprogesterone acetate (procedure)
administrering av depåpreventivmedel Administration of depot contraceptive (procedure)
lambå från musculus depressor anguli oris Depressor anguli oris myocutaneous flap
Depth of cells in anterior chamber Depth of anterior chamber
Derangement of meniscus, NEC Derangement of meniscus
Dermatitis atrophicans Acrodermatitis atrophicans chronica
dermatit orsakad av intagen substans och/eller läkemedel Dermatitis caused by substance taken via oral route (disorder)
dermatit orsakad av intagna substanser Dermatitis caused by substance taken via oral route (disorder)
Dermatitis due to other specified substance taken internally Dermatitis caused by substance taken via oral route (disorder)
dermatofibrom Dermatofibroma (morphologic abnormality)
dermatos som kan tillskrivas antikoagulans med kumarin Dermatosis caused by coumarin (disorder)
dermatos av misstänkt viral etiologi Suspected viral infection of skin (situation)
dermatos orsakad av immunhämmande behandling Dermatosis caused by immunosuppressant
Dermographism Dermatographic urticaria
Deroofing of cyst of organ NOC Surgical procedure (procedure)
flytande desfluran 99 % Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
desloratadin 0,5 mg/ml, sirap Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug)
desloratadin 2,5 mg/pseudoefedrin 120 mg, tablett med modifierad frisättning Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
desloratadin 5 mg/pseudoefedrin 240 mg, tablett med modifierad frisättning Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
desloratadin 5 mg + pseudoefedrin 240 mg, depåtablett Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
desmoplastiskt fibrom Desmoplastic fibroma
desmoplastiskt juvenilt gangliogliom Desmoplastic infantile astrocytoma
desmopressinacetat 0,01 %, lösning Product containing only desmopressin (medicinal product)
deoximetason 0,5 %, gel Product containing only desoximetasone (medicinal product)
Destruction of intervertebral disc by other specified method Vertebral column destructive procedure
Destruction of lesion of organ NOC NOS Destruction of lesion
Destruction of lesion of organ NOC OS Destruction of lesion
Destruction of tissue of heart Catheter ablation of tissue of heart
Destruction of tissue of pharynx Pharynx destructive procedure
Destructive procedure of facial bone Facial bone destructive procedure
Desulfotomaculum orientis Desulfosporosinus orientis
retinalavlossning i vänster öga samtidig med näthinnedefekt Detachment of left retina with retinal break
retinalavlossning i höger öga samtidig med näthinnedefekt Detachment of right retina with retinal break
detrusorhyperreflexi i urinblåsan Neurogenic detrusor overactivity
Detrusor instability Idiopathic detrusor overactivity (disorder)
Detrusor instability Idiopathic detrusor overactivity (disorder)
Detrusor instability Idiopathic detrusor overactivity (disorder)
blåsa med detrusorinstabilitet Idiopathic detrusor overactivity (disorder)
screening för utvecklingshandikapp Screening for developmental disorder (procedure)
dexametason 0,5 mg/5 ml, elixir Dexamethasone 100 microgram/mL oral solution
Dexamethasone sodium phospha 0.05% Dexamethasone only product in ocular dose form
dexametasonnatriumfosfat 0,05 %, ögondroppar Dexamethasone only product in ocular dose form
dexametasonnatriumfosfat 0,05 %, ögondroppar för engångsbruk Dexamethasone only product in ocular dose form
dexametason 0,1 % + hypromellos 0,5 %, ögondroppar Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution
dexamfetamin, icke läkemedel Dexamfetamine
dexlansoprazol 30 mg, depåkapsel med frisättning i två steg Dexlansoprazole 30 mg gastro-resistant oral capsule
dexlansoprazol 30 mg, kapsel med modifierad frisättning Dexlansoprazole 30 mg gastro-resistant oral capsule
dexlansoprazol 60 mg, depåkapsel med frisättning i två steg Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
dexlansoprazol 60 mg, kapsel med modifierad frisättning Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
dexmetylfenidat 20 mg, kapsel med modifierad frisättning Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
dexmetylfenidat 10 mg, depåkapsel Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
dexmetylfenidat 5 mg, kapsel med modifierad frisättning Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
dexmetylfenidat 5 mg, depåkapsel Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
dexonpatch Prosthetic patch
Dexonsutur Polyglycolic acid suture
dexrazoxanhydroklorid Product containing dexrazoxane (medicinal product)
Dextran 40 (10%), injektionsvätska, lösning, flaska 500 ml Dextran 40 100 mg/mL solution for injection
Dextran 40 10% injection Dextran 40 100 mg/mL solution for injection
Dextran 40 + dextros 5 %, injektionsvätska, lösning, påse Dextran 40 100 mg/mL solution for injection
Dextran 40 + natriumklorid 0,9 %, injektionsvätska, lösning, påse Dextran 40 100 mg/mL solution for injection
Dextran 70 in sodium chloride 7.5% infusion Dextran 70 only product in parenteral dose form
Dextran 70 i natriumklorid 7,5 %, infusionsvätska, lösning Dextran 70 only product in parenteral dose form
Dextran 70 + dextros 5 %, infusionsvätska, lösning, påse Dextran 70 only product in parenteral dose form
Dextran 70 + natriumklorid 0,9 %, infusionsvätska, lösning, påse Dextran 70 only product in parenteral dose form
dextranallergi Non-allergic hypersensitivity to dextran (finding)
dextroamfetaminsulfat 10 mg, kapsel med modifierad frisättning Dexamfetamine only product in oral dose form
dextroamfetaminsulfat 10 mg, depåkapsel Dexamfetamine only product in oral dose form
dextroamfetaminsulfat 15 mg, kapsel med modifierad frisättning Dexamfetamine only product in oral dose form
dextroamfetaminsulfat 15 mg, depåkapsel Dexamfetamine only product in oral dose form
dextroamfetaminsulfat 5 mg, kapsel med modifierad frisättning Dexamfetamine only product in oral dose form
dextroamfetaminsulfat 5 mg, depåkapsel Dexamfetamine only product in oral dose form
dextrometorfan 7,5 mg, pastill Dextromethorphan 7.5 mg oromucosal lozenge
dextrometorfanhydrobromid 15 mg + prometazinhydroklorid 6,25 mg, vätska Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution
dextrometorfanhydrobromid 6,67 mg/5 ml, sirap Dextromethorphan hydrobromide 1.33 mg/mL oral solution
dextrometorfanhydrobromid 7,5 mg/5 ml, oralt elixir Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
dextrometorfanhydrobromid 7,5 mg/5 ml, sirap Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
dextrometorfanhydrobromidallergi Allergy to dextromethorphan
Dextrose + lidocaine hydrochloride 7.5%ww/1.5%ww injection Lidocaine only product in parenteral dose form
dextros 10 %, lösning Product containing only glucose (medicinal product)
dextros 20 %, lösning Product containing only glucose (medicinal product)
dextros 25 %, lösning Product containing only glucose (medicinal product)
dextros 30 %, lösning Product containing only glucose (medicinal product)
dextros 40 %, lösning Product containing only glucose (medicinal product)
dextros 60 % i vatten, infusionsvätska, lösning, påse 1 000 ml Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 60 % i vatten, infusionsvätska, lösning, påse 500 ml Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 60 % i vatten, intravenös vätska, lösning, påse 1000 ml Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 60 % i vatten, intravenös vätska, lösning, påse 500 ml Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 60 %, lösning Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dextrose 60g injection Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 7,5 viktprocent + lidokainhydroklorid 1,5 viktprocent, injektionsvätska, lösning, flaska Lidocaine only product in parenteral dose form

Start Previous Page 32 of 153 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start